Trial Profile
Retrospective study of nebivolol as first add-on therapy compared with hydrochlorothiazide, metoprolol, and amlodipine in patients with inadequate response to initial treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2018
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Amlodipine; Hydrochlorothiazide; Metoprolol
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 10 Jul 2018 New trial record
- 01 Jun 2018 Results published in the Journal of Clinical Hypertension (Greenwich)